|
Investors
Events & presentations
Acomplia® Update
- To print this page, please use the File menu or press simultaneously ctrl + p keys.
- Send this page
November 5, 2008
On November 5, 2008, sanofi-aventis announced the discontinuation of all clinical trials with rimonabant.
At a conference call on October 23, 2008, the sanofi-aventis management reviewed its decision to suspend the marketing authorisation of Acomplia® in obese and overweight patients, complying with the EMEA’s recommendation.
Download documents
Recorded audio webcast held on October 23, 2008
|
Last update: Sept 02, 2010 05.35 PM (CET) Quote: €46.38. Level change: -0.52%
Last update: Sept 02, 2010 01.01 PM (EST)Quote: $29.68. Level change: -0.08%
Further information
Publications
|